Thomas Woiwode

Insider Reports History

Entity: Individual
Location: One Sansome Street, Suite 1650, San Francisco, CA
Signature: /s/ Edgar Cale, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Gritstone bio, Inc.	Director	Common Stock	128	$244	$1.90	Aug 25, 2021	Direct
Adverum Biotechnologies, Inc.	Director	Stock Option (Right to Buy)	40K			May 12, 2021	Direct
Passage BIO, Inc.	Director, 10%+ Owner	Director Stock Option (Right to Buy)	24K			May 25, 2023	Direct
Aligos Therapeutics, Inc.	Director	Stock Option (Right to Buy)	15K			Jun 23, 2022	Direct
Tempest Therapeutics, Inc.	Director	Stock Option (Right to Buy)	3.5K			Jun 17, 2022	Direct
Gritstone bio, Inc.	Director	Common Stock	0		$1.90	Aug 25, 2021	Indirect

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
PASG	Passage BIO, Inc.	May 25, 2023	1	$0	4	May 26, 2023	Director, 10%+ Owner
ALGS	Aligos Therapeutics, Inc.	Jun 23, 2022	1	$0	4	Jun 27, 2022	Director
TPST	Tempest Therapeutics, Inc.	Jun 17, 2022	1	$0	4	Jun 22, 2022	Director
PASG	Passage BIO, Inc.	May 26, 2022	1	$0	4	May 31, 2022	Director, 10%+ Owner
TPST	Tempest Therapeutics, Inc.	Apr 29, 2022	1	$5M	4	May 3, 2022	Director, 10%+ Owner
GRTS	Gritstone bio, Inc.	Aug 25, 2021	6	$0	4	Aug 27, 2021	Director
TPST	Tempest Therapeutics, Inc.	Jul 1, 2021	1	$0	4/A	Sep 20, 2021	Director
TPST	Millendo Therapeutics, Inc.	Jun 25, 2021	3	$0	4	Jun 29, 2021	Director, 10%+ Owner
TPST	Millendo Therapeutics, Inc.	Jun 25, 2021	0	$0	3	Jun 29, 2021	Director
ALGS	Aligos Therapeutics, Inc.	Jun 17, 2021	1	$0	4	Jun 17, 2021	Director
ALGS	Aligos Therapeutics, Inc.	Jun 11, 2021	6	$0	4	Jun 15, 2021	Director
PASG	Passage BIO, Inc.	May 27, 2021	1	$0	4	May 28, 2021	Director, 10%+ Owner
ADVM	Adverum Biotechnologies, Inc.	May 12, 2021	1	$0	4	May 14, 2021	Director